Medical Device CROs Market

  • ID: 4702514
  • Report
  • 320 Pages
  • Roots Analysis
1 of 5
Medical Device CRO Landscape is Highly Fragmented and Concentrated in Europe and North America

FEATURED COMPANIES

  • 1Med
  • Bioscience
  • Cvigilance
  • International HealthCare
  • NCGS
  • Q-Trials
  • MORE

According to the World Bank, more than 50,000 different types of medical devices are currently being used every day in health care facilities worldwide. In 2018, the global medical devices market is estimated to reach a net worth of approximately USD 450 billion. Further, another study estimated that the number of medical device-related trials increased by 63% in the period between 2012 and 2016. However, a relatively larger proportion of device developers lack the required internal resources and technical expertise to conduct in-house clinical trials. Moreover, the costs associated with acquiring the necessary infrastructure / capabilities for such elaborate research initiatives are high; therefore, it is difficult for companies with limited finances to initiate and manage clinical studies by themselves. In addition, the implementation of highly stringent regulatory guidelines, specifically for devices posing medium to high risk to consumers, render them subject to rigorous quality assessments. The aforementioned challenges have led several players in the industry to outsource a significant part of their clinical stage research efforts to capable contract research organizations (CROs).

In the foreseen future, the growing complexity of clinical trials and demand for reliable evidence on therapeutic benefits offered by various medical devices are likely to prompt more developer companies to outsource various aspects of their operations. The evolving practices have led a number of new players to enter the contract services domain. Moreover, in order to cope up with emerging technologies and the latest research trends, several legacy CROs are also re-evaluating their operational models and business strategies. In addition, the demand for integrated data platforms to manage and analyze a vast amount of data, coupled with challenges associated with unstructured datasets and data privacy, has resulted in several collaboration and acquisition agreements between CROs and data management solutions providers. It is also worth highlighting that the industry has witnessed some consolidation in the last five years as smaller players have been acquired in an effort to widen the parent company’s geographical reach.

The ‘Medical Device CROs Market, 2018-2030’ report features a comprehensive study on the current landscape of contract research service providers focused on medical devices. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:

  • An overview of the current market landscape, featuring a comprehensive list of CROs, and detailed analysis of the research service providers based on a number of parameters, such as geographical location, year of establishment, company size, scale of operation (clinical and preclinical), types of services provided by [A] clinical service providers  (biostatistics, consulting, clinical operations, post-marketing surveillance / studies, quality assurance, regulatory affairs management, reimbursement, resourcing, and training), [B] preclinical service providers (consulting, biocompatibility testing, materials characterization and analytical testing, preclinical trials support, sterility testing and microbiology testing, and training) and [C] stand-alone service providers (biostatistics, consulting, data management, pharmacovigilance, quality assurance, and regulatory affairs management), and popular therapeutic areas.
  • An elaborate discussion of the various guidelines established by major regulatory bodies for medical device approval, across different countries. The report also features an insightful multi-dimensional, heat map analysis, featuring a comparison of the contemporary regulatory scenario in key geographies across the globe.
  • Comprehensive profiles of popular players that specialize in providing services for both clinical and preclinical stage medical device development. Each profile features an overview of the company, its financial performance (if available), service portfolio details, and a future outlook.
  • A benchmark analysis, highlighting the key focus areas of small-sized, mid-sized and large companies, comparing their existing capabilities within and beyond their respective peer groups, providing a means for stakeholders to identify ways to gain a competitive edge in the industry.
  • A comprehensive geographical clinical trial analysis of ongoing and planned studies related to medical devices. It provides details related to medical devices being investigated across various geographies, based on the number of registered trials, the current status of trials, therapeutic area(s) and disease indication(s), and the number of patients enrolled.
  • A detailed analysis of the mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2012-2018, along with the geographical distribution of this activity. The analysis also features an ownership change matrix, providing a summary of the involvement of private and public sector entities in this domain.
  • A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing CRO services to medical device developers.
  • A discussion on affiliated trends, key drivers and challenges, under a comprehensive SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall medical device CRO industry.
  • An elaborate discussion on the future opportunities / trends for the medical device outsourcing market that are likely to influence the growth of this domain over the coming years.

Example Highlights

  • With more than 300 CROs focused on the development of medical devices, the market landscape is highly fragmented, featuring a mix of small-sized (1,000 employees, 5%). Examples of established players (more than 1,000 employees, no selection criteria) include Charles River Laboratories, Chiltern, CMIC Group, Eurofins Scientific, FMD K&L, ICON, Medpace, NAMSA, Novella Clinical, PAREXEL International, Pharmaceutical Product Development (PPD), Promedica International, Syneos Health and WuXi AppTec.
  • Most of the aforementioned CROs (82%) are based in North America and Europe. However, a relatively growing proportion of such players are situated in the Asia Pacific region, catering to the needs of emerging economies, such as China and India. Examples of companies that have recently (since 2015) entered the domain include (in alphabetical order, no selection criteria) 1MED, AccuLab Life Sciences, Axcent Advanced Analytics, Azelix, BioAgile Therapeutics, CarthoPharma, CTServ, dMed, dn8 collaborate, Dove Quality Solutions, Firma Clinical Research, MedQ Consultants, NOVO Consulting Group, Pepgra, Proxima Research, Remo CRO, RMF Clinical and Scope International.
  • Close to 7,000 clinical studies for medical devices, having enrolled more than three million patients, were registered (ongoing / planned) across different geographies in the last five years alone. It is worth mentioning that, amongst others, cardiovascular disorders (12%) and oncological disorders (9%) have emerged as prominent therapeutic areas being targeted by medical device developers. Within cardiovascular disorders, indications, such as stroke and coronary artery disease, have emerged as prominent conditions, whereas in the case of oncology, breast cancer and lung cancer are presently the most commonly targeted indications.
  • Over 35 mergers and acquisitions have taken place among stakeholders in this domain, during the period 2012-2018. Companies that were recently acquired include (in the chronological order of their acquisition) Hilbert Paradox (March 2018), MPI Research (April 2018), Fiver Corners (June 2018), Cobridge (September 2018) and DZS Clinical Services (September 2018).
  • Driven by the growing technical and regulatory complexities related to medical device development, the demand for contract services providers is anticipated to increase in the coming years. Overall, we expect the market to grow at an annualized rate of 6.3% between 2018 and 2030. Contract services for clinical operations management currently capture a relatively higher (73%) share in the medical device CROs market. This trend is unlikely to change in the foreseen future. The rest of the market is distributed across data management (16%), regulatory (6%) and other types of services, including consulting, quality assurance, reimbursement, and post-market surveillance.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 1Med
  • Bioscience
  • Cvigilance
  • International HealthCare
  • NCGS
  • Q-Trials
  • MORE

1. Preface
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
 
2. Executive Summary
 
3. Introduction
3.1. Chapter Overview
3.2. An Overview of Contract Research Organizations (CROs)
3.2.1. Evolution of CROs
3.3. Role of CROs in the Medical Device Industry
3.3.1. Types of Medical Device CROs
3.4. Services Offered by CROs
3.5. Key Factors in CRO Selecting a CRO Partner
3.6. Risks and Challenges Associated with CROs
 
4. Medical Device Cros: Current Market Landscape
4.1. Chapter Overview
4.2. Medical Device CROs: Overall Market Overview
4.2.1. Analysis by Scale of Operation
4.3. Medical Device CROs: Clinical Service Providers
4.3.1. Analysis by Geography
4.3.2. Analysis by Year of Establishment
4.3.3. Analysis by Company Size
4.3.4. Analysis by Type of Services
4.4. Medical Device CROs: Preclinical Service Providers
4.4.1. Analysis by Geography
4.4.2. Analysis by Year of Establishment
4.4.3. Analysis by Company Size
4.4.4. Analysis by Type of Services
4.5. Medical Device CROs: Stand-alone Service Providers
 
5. Regulatory Landscape For Medical Devices
5.1. Chapter Overview
5.2. Regulatory Guidelines in North America
5.2.1.The US Scenario
5.2.2. Canadian Scenario
5.3. Regulatory Guidelines in Europe
5.4. Regulatory Guidelines in Asia Pacific and Rest of the World
5.4.1.Japanese Scenario
5.4.2.Chinese Scenario
5.4.3. South African Scenario
5.5. Heat Map Analysis: Comparison of Regional Regulatory Control
 
6. Company Profiles
6.1.Chapter Overview
6.2.Charles River Laboratories
6.2.1. Company Snapshot
6.2.1.1 Financial Performance
6.2.2. Service Portfolio
6.2.3. Future Outlook
6.3. Clinlogix
6.3.1.Company Snapshot
6.3.2.Service Portfolio
6.3.3.Future Outlook
6.4. CROMSOURCE
6.4.1.Company Snapshot
6.4.2.Service Portfolio
6.4.3.Future Outlook
6.5.CSSi Life Sciences
6.5.1.Company Snapshot
6.5.2.Service Portfolio
6.5.3.Future Outlook
6.6. Eurofins Scientific
6.6.1. Company Snapshot
6.6.1.1.Financial Performance
6.6.2.Service Portfolio
6.6.3. Future Outlook
6.7. Factory CRO
6.7.1. Company Snapshot
6.7.2. Service Portfolio
6.7.3. Future Outlook
6.8. genae
6.8.1. Company Snapshot
6.8.2. Service Portfolio
6.8.3. Future Outlook
6.9. IMARC Research
6.9.1. Company Snapshot
6.9.2. Service Portfolio
6.9.3. Future Outlook
6.10. Medpace
6.10.1. Company Snapshot
6.10.1.1. Financial Information
6.10.2. Service Portfolio
6.10.3. Future Outlook
6.11. NAMSA
6.11.1. Company Snapshot
6.11.2. Service Portfolio
6.11.3. Future Outlook
6.12. Novella Clinical
6.12.1. Company Snapshot
6.12.2. Service Portfolio
6.12.3. Future Outlook
6.13. Qserve
6.13.1. Company Snapshot
6.13.2. Service Portfolio
6.13.3. Future Outlook
6.14. RCRI
6.14.1. Company Snapshot
6.14.2. Service Portfolio
6.14.3. Future Outlook
6.15. WuXi AppTec
6.15.1. Company Snapshot
6.15.1.1. Service Portfolio
6.15.2. Future Outlook
 
7. Benchmark Analysis
7.1. Chapter Overview
7.2. Benchmark Analysis: Methodology
7.3. Benchmark Analysis: Peer Groups
7.3.1. North America, Peer Group I
7.3.2. North America, Peer Group II
7.3.3. North America, Peer Group III
7.3.4. Europe, Peer Group IV
7.3.5. Europe, Peer Group V
7.3.6. Asia Pacific, Peer Group VI
7.3.7. Asia Pacific, Peer Group VII
 
8. Clinical Trial Analysis
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Medical Devices: Clinical Trial Analysis
8.3.1. Analysis by Trial Start Year
8.3.2. Analysis by Trial Status
8.3.3. Analysis by Trial Status and Start Year
8.3.4. Analysis by Target Therapeutic Area
8.3.5. Analysis by Target Indication
8.3.6. Analysis by Target Therapeutic Area and Indication
8.3.7. Geographical Analysis by Number of Clinical Trials
8.3.8. Geographical Analysis by Number of Enrolled Patients
8.3.9. Geographical Analysis by Number of Trials and Recruitment Status
8.3.10. Geographical Analysis by Number of Enrolled Patients and Recruitment Status
 
9. Mergers And Acquisitions
9.1. Chapter Overview
9.2. Medical Device CROs: Mergers and Acquisitions
9.2.1. Year-wise Trend
9.2.2. Geographical Activity
9.2.3. Ownership Change Matrix
9.2.4. Analysis by Type of Company
 
10. Survey Insights
10.1. Chapter Overview
10.2. Designation of Respondents
10.3. Type of Services
10.4. Therapeutic Area
10.5. Number of Annual Projects
10.6. Likely Market Opportunity
 
11. Market Sizing And Forecast
11.1. Chapter Overview
11.2. Scope of the Forecast
11.3. Forecast Methodology
11.4. Overall Medical Device CROs Market, 2018-2030
11.4.1. Medical Device CROs Market, 2018-2030: Distribution by Therapeutic Area
11.4.2. Medical Device CROs Market, 2018-2030: Distribution by Scale of Operation
11.4.3. Medical Device CROs Market, 2018-2030: Distribution by Device Class
11.4.4. Medical Device CROs Market, 2018-2030: Distribution by Type of Services
11.4.5. Medical Device CROs Market, 2018-2030: Distribution by Geography
11.5. Medical Device CROs Market in North America, 2018-2030
11.5.1. Medical Device CROs Market in North America, 2018-2030: Distribution by Therapeutic Area
11.5.1.10. Medical Device CROs Market for Other Therapeutic Areas in North America, 2018-2030
11.5.2. Medical Device CROs Market in North America, 2018-2030: Distribution by Device Class
11.5.3. Medical Device CROs Market in North America, 2018-2030: Distribution by Type of Services
11.6. Medical Device CROs Market in Europe, 2018-2030
11.6.1. Medical Device CROs Market in Europe, 2018-2030: Distribution by Therapeutic Area
11.6.1.10. Medical Device CROs Market for Other Therapeutic Areas in Europe, 2018-2030
11.6.2. Medical Device CROs Market in Europe, 2018-2030: Distribution by Device Class
11.6.3. Medical Device CROs Market in Europe, 2018-2030: Distribution by Type of Services
11.7. Medical Device CROs Market in Asia-Pacific, 2018-2030
11.7.1. Medical Device CROs Market in Asia-Pacific, 2018-2030: Distribution by Therapeutic Area
11.7.1.10. Medical Device CROs Market for Other Therapeutic Areas in Asia-Pacific, 2018-2030
11.7.2. Medical Device CROs Market in Asia-Pacific, 2018-2030: Distribution by Device Class
11.7.3. Medical Device CROs Market in Asia-Pacific, 2018-2030: Distribution by Type of Services
11.8. Medical Device CROs Market in Rest of The World, 2018-2030
11.8.1. Medical Device CROs Market in Rest of The World, 2018-2030: Distribution by Therapeutic Area
11.8.1.10. Medical Device CROs Market for Other Therapeutic Areas in Rest of The World, 2018-2030
11.8.2. Medical Device CROs Market in Rest of the World, 2018-2030: Distribution by Device Class
11.8.3. Medical Device CROs Market in Rest of the World, 2018-2030: Distribution by Type of Services
 
12. SWOT Analysis
12.1. Chapter Overview
12.2. Strengths
12.3. Weaknesses
12.4. Opportunities
12.5. Threats
12.6. Concluding Remarks
 
13. Future Trends And Opportunities
13.1.Chapter Overview
13.2. Growing Number of Connected Devices
13.3. Rise in Data Analytics and Real-Time Monitoring Solutions
13.4. Need for Cloud-based Solutions to Handle Growing Volumes of Medical Data
13.5. Increasing Preferences for Real World Evidence Data for Regulatory Approval
13.6. Concluding Remarks
 
14. Interview And Survey Transcripts
 
15. Appendix 1: Tabulated Data
 
16. Appendix 2: List Of Companies And Organizations

List of Tables
Table 4.1 Medical Device CROs: List of Clinical Service Providers
Table 4.2 Medical Device CROs: Information on Services
Table 4.3 Medical Device CROs: Information on Clinical Research Services
Table 4.4 Medical Device CROs: Information on Regulatory Services
Table 4.5 Medical Device CROs: List of Preclinical Service Providers
Table 4.6 Medical Device CROs: Information on Services
Table 4.7 Medical Device CROs: List of Standalone Service Providers
Table 5.1 Device Classification: US
Table 5.2 Device Classification: Canada
Table 5.3 Device Classification: Europe
Table 5.4 Regulatory Bodies in EU5 Countries
Table 5.5 List of CE Marking Directives in Europe
Table 5.6 Conformity Assessment Modules in Europe
Table 5.7 Device Classification: Japan
Table 5.8 Device Classification: China
Table 5.9 Device Classification: South Africa
Table 6.1 Charles River Laboratories: Company Snapshot
Table 6.2 Charles River Laboratories: Future Outlook
Table 6.3 Clinlogix: Company Snapshot
Table 6.4 Clinlogix: Future Outlook
Table 6.5 CROMSOURCE: Company Snapshot
Table 6.6 CROMSOURCE: Future Outlook
Table 6.7 CSSi Life Sciences: Company Snapshot
Table 6.8 CSSi Life Sciences: Future Outlook
Table 6.9 Eurofins Scientific: Company Snapshot
Table 6.10 Eurofins Scientific: Future Outlook
Table 6.11 Factory CRO: Company Snapshot
Table 6.12 Factory CRO: Future Outlook
Table 6.13 genae: Company Snapshot
Table 6.14 genae: Future Outlook
Table 6.15 IMARC Research: Company Snapshot
Table 6.16 IMARC Research: Future Outlook
Table 6.17 Medpace: Company Snapshot
Table 6.18 Medpace: Future Outlook
Table 6.19 NAMSA: Company Snapshot
Table 6.20 NAMSA: Future Outlook
Table 6.21 Novella Clinical: Company Snapshot
Table 6.22 Novella Clinical: Future Outlook
Table 6.23 Qserve: Company Snapshot
Table 6.24 Qserve: Future Outlook
Table 6.25 RCRI: Company Snapshot
Table 6.26 RCRI: Future Outlook
Table 6.27 WuXi AppTec: Company Snapshot
Table 6.28 WuXi AppTec: Future Outlook
Table 7.1 Benchmark Analysis: Peer Groups
Table 9.1 Medical Device CROs Market: Mergers and Acquisitions
Table 10.1 Survey Insights: Overview of Respondents
Table 10.2 Survey Insights: Designation and Seniority Level
Table 10.3 Survey Insights: Type of Services
Table 10.4 Survey Insights: Therapeutic Area
Table 10.5 Survey Insights: Number of Annual Projects
Table 10.6 Survey Insights: Likely Market Opportunity
Table 15.1 Medical Device CROs: Analysis by Scale of Operation
Table 15.2 Medical Device CROs: Analysis by Geography
Table 15.3 Medical Device CROs: Analysis by Year of Establishment
Table 15.4 Medical Device CROs: Analysis by Company Size
Table 15.5 Medical Device CROs: Analysis by Clinical Services
Table 15.6 Medical Device CROs: Analysis by Clinical Research Services
Table 15.7 Medical Device CROs: Analysis by Regulatory Services
Table 15.8 Medical Device CROs: Analysis by Preclinical Services
Table 15.9 Charles River Laboratories: Annual Revenues, 2013-H1 2018 (USD Billion)
Table 15.10 Eurofins Scientific: Annual Revenues, 2013-H1 2018 (USD Billion)
Table 15.11 Medpace: Annual Revenues, 2013-H1 2018 (USD Million)
Table 15.12 Benchmark Analysis: Regional Distribution of Companies by Size
Table 15.13 Benchmark Analysis: North America, Peer Group I
Table 15.14 Benchmark Analysis: North America, Peer Group II
Table 15.15 Benchmark Analysis: North America, Peer Group III
Table 15.16 Benchmark Analysis: Europe, Peer Group IV
Table 15.17 Benchmark Analysis: Europe, Peer Group V
Table 15.18 Benchmark Analysis: Asia-Pacific, Peer Group VI
Table 15.19 Benchmark Analysis: Asia-Pacific, Peer Group VII
Table 15.20 Clinical Trial Analysis: Distribution of Trials by Start Year, 2013-2018
Table 15.21 Clinical Trial Analysis: Distribution by Trial Status
Table 15.22 Clinical Trial Analysis: Distribution by Trial Status and Start Year
Table 15.23 Clinical Trial Analysis: Distribution by Target Therapeutic Area
Table 15.24 Clinical Trial Analysis: Distribution by Target Indication
Table 15.25 Clinical Trial Analysis: Distribution by Target Therapeutic Area and Indication
Table 15.26 Mergers and Acquisitions: Distribution by International and Local Acquisitions
Table 15.27 Mergers and Acquisitions: Distribution by Type of Company
Table 15.28 Survey Analysis: Distribution by Type of Organization
Table 15.29 Survey Analysis: Distribution by Location of Headquarters
Table 15.30 Survey Analysis: Distribution by Seniority Level of Respondents
Table 15.31 Survey Analysis: Distribution by Type of Services
Table 15.32 Survey Analysis: Distribution by Therapeutic Area
Table 15.33 Survey Analysis: Distribution by Number of Annual Projects
Table 15.34 Survey Analysis: Distribution by Likely Market Opportunity
Table 15.35 Overall Medical Device CROs Market, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.36 Medical Device CROs Market: Distribution by Therapeutic Area, 2018-2030 (USD Billion)
Table 15.37 Medical Device CROs Market: Distribution by Scale of Operation, 2018-2030 (USD Billion)
Table 15.38 Medical Device CROs Market: Distribution by Device Class, 2018-2030 (USD Billion)
Table 15.39 Medical Device CROs Market: Distribution by Type of Services, 2018-2030 (USD Billion)
Table 15.40 Medical Device CROs Market: Distribution by Geography, 2018-2030 (USD Billion)
Table 15.41 Medical Device CROs Market in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.42 Medical Device CROs Market for Bone Disorders in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.43 Medical Device CROs Market for Cardiovascular Disorders in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.44 Medical Device CROs Market for Dental Disorders in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.45 Medical Device CROs Market for Metabolic Disorders in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.46 Medical Device CROs Market for Neurological Disorders in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.47 Medical Device CROs Market for Ophthalmic Disorders in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.48 Medical Device CROs Market for Oncological Disorders in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.49 Medical Device CROs Market for Respiratory Disorders in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.50 Medical Device CROs Market for Wound Management in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.51 Medical Device CROs Market for Other Therapeutic Areas in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.52 Medical Device CROs Market for Class I Devices in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.53 Medical Device CROs Market for Class II Devices in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.54 Medical Device CROs Market for Class III Devices in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.55 Medical Device CROs Market for Clinical Trial Services in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.56 Medical Device CROs Market for Data Management Services in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.57 Medical Device CROs Market for Regulatory Services in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.58 Medical Device CROs Market for Consulting Services in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.59 Medical Device CROs Market for Other Services in North America, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.60 Medical Device CROs Market in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.61 Medical Device CROs Market for Bone Disorders in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.62 Medical Device CROs Market for Cardiovascular Disorders in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.63 Medical Device CROs Market for Dental Disorders in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.64 Medical Device CROs Market for Metabolic Disorders in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.65 Medical Device CROs Market for Neurological Disorders in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.66 Medical Device CROs Market for Ophthalmic Disorders in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.67 Medical Device CROs Market for Oncological Disorders in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.68 Medical Device CROs Market for Respiratory Disorders in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.69 Medical Device CROs Market for Wound Management in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.70 Medical Device CROs Market for Other Therapeutic Areas in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.71 Medical Device CROs Market for Class I Devices in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.72 Medical Device CROs Market for Class II Devices in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.73 Medical Device CROs Market for Class III Devices in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.74 Medical Device CROs Market for Clinical Trial Services in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.75 Medical Device CROs Market for Data Management Services in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.76 Medical Device CROs Market for Regulatory Services in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.77 Medical Device CROs Market for Consulting Services in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.78 Medical Device CROs Market for Other Services in Europe, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.79 Medical Device CROs Market in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.80 Medical Device CROs Market for Bone Disorders in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.81 Medical Device CROs Market for Cardiovascular Disorders in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.82 Medical Device CROs Market for Dental Disorders in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.83 Medical Device CROs Market for Metabolic Disorders in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.84 Medical Device CROs Market for Neurological Disorders in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.85 Medical Device CROs Market for Ophthalmic Disorders in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.86 Medical Device CROs Market for Oncological Disorders in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.87 Medical Device CROs Market for Respiratory Disorders in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.88 Medical Device CROs Market for Wound Management in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.89 Medical Device CROs Market for Other Therapeutic Areas in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.90 Medical Device CROs Market for Class I Devices in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.91 Medical Device CROs Market for Class II Devices in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.92 Medical Device CROs Market for Class III Devices in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.93 Medical Device CROs Market for Clinical Trial Services in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.94 Medical Device CROs Market for Data Management Services in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.95 Medical Device CROs Market for Regulatory Services in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.96 Medical Device CROs Market for Consulting Services in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.97 Medical Device CROs Market for Other Services in Asia-Pacific, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.98 Medical Device CROs Market in Rest of the World, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.99 Medical Device CROs Market in Rest of the World, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion): Distribution by Therapeutic Area
Table 15.100 Medical Device CROs Market for Bone Disorders in Rest of the World, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.101 Medical Device CROs Market for Cardiovascular Disorders in Rest of the World, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)
Table 15.102 Medical Device CROs Market for Dental Disorders in Rest of the World, Conservative Scenario, Base Scenario and Optimistic Scenario, 2018-2030 (USD Billion)

List of Figures
Figure 3.1 Medical Devices: Development Process
Figure 3.2 Medical Devices: Outsourcing Models
Figure 3.3 Range of Services Offered by CROs
Figure 3.4 Key Factors in Selecting a CRO Partner
Figure 3.5 Risks / Challenges Associated with CROs
Figure 4.1 Medical Device CROs: Distribution by Scale of Operation
Figure 4.2 Medical Device CROs: Distribution by Geography
Figure 4.3 Medical Device CROs: Distribution by Year of Establishment
Figure 4.4 Medical Device CROs: Distribution by Company Size
Figure 4.5 Medical Device CROs: Distribution by Services
Figure 4.6 Medical Device CROs: Distribution by Clinical Research Services
Figure 4.7 Medical Device CROs: Distribution by Regulatory Services
Figure 4.8 Medical Device CROs: Distribution by Preclinical Services
Figure 5.1 Medical Device Approval Process: US
Figure 5.2 Medical Device Approval Process: Canada
Figure 5.3 Medical Device Approval Process: Europe
Figure 5.4 Medical Device Approval Process: Japan
Figure 5.5 Medical Device Approval Process: China
Figure 5.6 Medical Device Approval Process: South Africa
Figure 5.7 Heat Map Analysis: Comparison of Regional Regulatory Control
Figure 5.8 Summary of Regional Regulatory Control
Figure 6.1 Charles River Laboratories: Annual Revenues, 2013-H1 2018 (USD Billion)
Figure 6.2 Charles River Laboratories: Service Portfolio
Figure 6.3 Clinlogix: Service Portfolio
Figure 6.4 CROMSOURCE: Service Portfolio
Figure 6.5 CSSi Life Sciences: Service Portfolio
Figure 6.6 Eurofins Scientific: Annual Revenues, 2013-H1 2018 (USD Billion)
Figure 6.7 Eurofins Scientific: Service Portfolio
Figure 6.8 Factory CRO: Service Portfolio
Figure 6.9 genae: Service Portfolio
Figure 6.10 IMARC Research: Service Portfolio
Figure 6.11 Medpace: Annual Revenues, 2013-H1 2018 (USD Million)
Figure 6.12 Medpace: Service Portfolio
Figure 6.13 NAMSA: Service Portfolio
Figure 6.14 Novella Clinical: Service Portfolio
Figure 6.15 Qserve: Service Portfolio
Figure 6.16 RCRI: Service Portfolio
Figure 6.17 WuXi AppTec: Service Portfolio
Figure 7.1 Benchmark Analysis: Regional Distribution of Companies by Size
Figure 7.2 Benchmark Analysis: North America, Peer Group I
Figure 7.3 Benchmark Analysis: North America, Peer Group II
Figure 7.4 Benchmark Analysis: North America, Peer Group III
Figure 7.5 Benchmark Analysis: Europe, Peer Group IV
Figure 7.6 Benchmark Analysis: Europe, Peer Group V
Figure 7.7 Benchmark Analysis: Asia-Pacific, Peer Group VI
Figure 7.8 Benchmark Analysis: Asia-Pacific, Peer Group VII
Figure 8.1 Clinical Trial Analysis: Distribution of Trials by Start Year, 2013-2018
Figure 8.2 Clinical Trial Analysis: Distribution by Trial Status
Figure 8.3 Clinical Trial Analysis: Distribution by Trial Status and Start Year
Figure 8.4 Clinical Trial Analysis: Distribution by Target Therapeutic Area
Figure 8.5 Clinical Trial Analysis: Distribution by Target Indication
Figure 8.6 Clinical Trial Analysis: Distribution by Target Therapeutic Area and Indication
Figure 8.7 Geographical Clinical Trial Analysis: Distribution by Number of Trials
Figure 8.8 Geographical Clinical Trial Analysis: Distribution by Number of Enrolled Patients
Figure 8.9 Geographical Clinical Trial Analysis: Distribution by Recruitment Status
Figure 8.10 Geographical Clinical Trial Analysis: Distribution by Number of Enrolled Patients
Figure 9.1 Mergers and Acquisitions: Year-Wise Trend
Figure 9.2 Mergers and Acquisitions: Geographical Activity
Figure 9.3 Mergers and Acquisitions: Intercontinental and Intracontinental Acquisitions
Figure 9.4 Mergers and Acquisitions: Ownership Change Matrix
Figure 9.5 Mergers and Acquisitions: Distribution by Type of Company
Figure 10.1 Survey Analysis: Distribution by Type of Organization
Figure 10.2 Survey Analysis: Distribution by Location of Headquarters
Figure 10.3 Survey Analysis: Distribution by Seniority Level of Respondents
Figure 10.4 Survey Analysis: Distribution by Type of Services
Figure 10.5 Survey Analysis: Distribution by Therapeutic Area
Figure 10.6 Survey Analysis: Distribution by Number of Annual Projects
Figure 10.7 Survey Analysis: Distribution by Likely Market Opportunity
Figure 11.1 Overall Medical Device CROs Market, Base Scenario, 2018-2030 (USD Billion)
Figure 11.2 Medical Device CROs Market: Distribution by Therapeutic Area, 2018-2030 (USD Billion)
Figure 11.3 Medical Device CROs Market: Distribution by Scale of Operation, 2018-2030 (USD Billion)
Figure 11.4 Medical Device CROs Market: Distribution by Device Class, 2018-2030 (USD Billion)
Figure 11.5 Medical Device CROs Market: Distribution by Type of Services, 2018-2030 (USD Billion)
Figure 11.6 Medical Device CROs Market: Distribution by Geography, 2018-2030 (USD Billion)
Figure 11.7 Medical Device CROs Market in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.8 Medical Device CROs Market for Bone Disorders in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.9 Medical Device CROs Market for Cardiovascular Disorders in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.10 Medical Device CROs Market for Dental Disorders in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.11 Medical Device CROs Market for Metabolic Disorders in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.12 Medical Device CROs Market for Neurological Disorders in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.13 Medical Device CROs Market for Ophthalmic Disorders in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.14 Medical Device CROs Market for Oncological Disorders in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.15 Medical Device CROs Market for Respiratory Disorders in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.16 Medical Device CROs Market for Wound Management in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.17 Medical Device CROs Market for Other Therapeutic Areas in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.18 Medical Device CROs Market for Class I Devices in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.19 Medical Device CROs Market for Class II Devices in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.20 Medical Device CROs Market for Class III Devices in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.21 Medical Device CROs Market for Clinical Trial Services in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.22 Medical Device CROs Market for Data Management Services in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.23 Medical Device CROs Market for Regulatory Services in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.24 Medical Device CROs Market for Consulting Services in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.25 Medical Device CROs Market for Other Services in North America, Base Scenario, 2018-2030 (USD Billion)
Figure 11.26 Medical Device CROs Market in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.27 Medical Device CROs Market for Bone Disorders in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.28 Medical Device CROs Market for Cardiovascular Disorders in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.29 Medical Device CROs Market for Dental Disorders in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.30 Medical Device CROs Market for Metabolic Disorders in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.31 Medical Device CROs Market for Neurological Disorders in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.32 Medical Device CROs Market for Ophthalmic Disorders in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.33 Medical Device CROs Market for Oncological Disorders in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.34 Medical Device CROs Market for Respiratory Disorders in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.35 Medical Device CROs Market for Wound Management in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.36 Medical Device CROs Market for Other Therapeutic Areas in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.37 Medical Device CROs Market for Class I Devices in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.38 Medical Device CROs Market for Class II Devices in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.39 Medical Device CROs Market for Class III Devices in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.40 Medical Device CROs Market for Clinical Trial Services in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.41 Medical Device CROs Market for Data Management Services in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.42 Medical Device CROs Market for Regulatory Services in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.43 Medical Device CROs Market for Consulting Services in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.44 Medical Device CROs Market for Other Services in Europe, Base Scenario, 2018-2030 (USD Billion)
Figure 11.45 Medical Device CROs Market in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.46 Medical Device CROs Market for Bone Disorders in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.47 Medical Device CROs Market for Cardiovascular Disorders in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.48 Medical Device CROs Market for Dental Disorders in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.49 Medical Device CROs Market for Metabolic Disorders in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.50 Medical Device CROs Market for Neurological Disorders in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.51 Medical Device CROs Market for Ophthalmic Disorders in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.52 Medical Device CROs Market for Oncological Disorders in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.53 Medical Device CROs Market for Respiratory Disorders in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.54 Medical Device CROs Market for Wound Management in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.55 Medical Device CROs Market for Other Therapeutic Areas in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.56 Medical Device CROs Market for Class I Devices in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.57 Medical Device CROs Market for Class II Devices in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.58 Medical Device CROs Market for Class III Devices in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.59 Medical Device CROs Market for Clinical Trial Services in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.60 Medical Device CROs Market for Data Management Services in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.61 Medical Device CROs Market for Regulatory Services in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.62 Medical Device CROs Market for Consulting Services in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.63 Medical Device CROs Market for Other Services in Asia-Pacific, Base Scenario, 2018-2030 (USD Billion)
Figure 11.64 Medical Device CROs Market in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.65 Medical Device CROs Market in Rest of the World, Base Scenario, 2018-2030 (USD Billion): Distribution by Therapeutic Area
Figure 11.66 Medical Device CROs Market for Bone Disorders in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.67 Medical Device CROs Market for Cardiovascular Disorders in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.68 Medical Device CROs Market for Dental Disorders in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.69 Medical Device CROs Market for Metabolic Disorders in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.70 Medical Device CROs Market for Neurological Disorders in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.71 Medical Device CROs Market for Ophthalmic Disorders in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.72 Medical Device CROs Market for Oncological Disorders in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.73 Medical Device CROs Market for Respiratory Disorders in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.74 Medical Device CROs Market for Wound Management in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.75 Medical Device CROs Market for Other Therapeutic Areas in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.76 Medical Device CROs Market for Class I Devices in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.77 Medical Device CROs Market for Class II Devices in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.78 Medical Device CROs Market for Class III Devices in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.79 Medical Device CROs Market for Clinical Trial Services in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.80 Medical Device CROs Market for Data Management Services in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.81 Medical Device CROs Market for Regulatory Services in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.82 Medical Device CROs Market for Consulting Services in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 11.83 Medical Device CROs Market for Other Services in Rest of the World, Base Scenario, 2018-2030 (USD Billion)
Figure 12.1 Medical Device CROs Market: SWOT Analysis
Figure 12.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 13.1 Overall Medical Device CROs Market, Conservative, Base and Optimistic Scenarios, 2018, 2025 and 2030 (USD Billion)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 1Med
  • Bioscience
  • Cvigilance
  • International HealthCare
  • NCGS
  • Q-Trials
  • MORE

Research Methodology

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry, medical practice and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy document
  • Industry analysts’ views

While the focus has been on forecasting the market till 2030, the report also provides our independent view on various non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

Chapter Outlines

  • Chapter 2 provides an executive summary of the insights captured in our research. It offers a high-level view on the current state of the medical device CROs market and its likely evolution in the short-mid term and long term.
  • Chapter 3 is a general overview of the various types of CROs in the pharmaceutical / medical device market. It provides a brief introduction to the concept of CROs, featuring a discussion on the historical evolution of contract research services market in the medical devices industry. Further, it elaborates on the need for outsourcing in this domain, along with the various partnership models that have been adopted by CROs and sponsors in the medical device industry, highlighting key points that developer companies need to consider for selecting a suitable contract research services provider. The chapter also features an exhaustive list of services offered by contemporary CROs, along with a discussion on the various challenges associated with this market.
  • Chapter 4 provides a comprehensive overview of the global landscape of medical device CROs. It includes information related to over 300 companies that are actively involved in the medical devices industry. It features an in-depth market review, including regional distribution, analysis by company size, year of establishment, scale of operation, types of services offered by clinical, preclinical and stand-alone service providers, and prominent therapeutic areas.
  • Chapter 5 featuresa detailed discussion on various guidelines established by major regulatory bodies for medical device approval, across different countries. The report also features an insightful heat map analysis, featuring a comparison of the contemporary regulatory scenario in key geographies, across the globe.
  • Chapter 6 features detailed profiles of popular players that specialize in providing services for both clinical and preclinical stage medical device development. Each profile features an overview of the company, its financial performance (if available), service portfolio details, and a future outlook.
  • Chapter 7 presents a benchmark analysis of the various players engaged in this domain. It highlights the capabilities of small-sized, mid-sized and large companies in terms of their expertise in medical device services. The analysis allows companies to compare their existing capabilities within and beyond their respective peer groups, providing a means for stakeholders to identify ways to gain a competitive edge in the industry.
  • Chapter 8 presents a comprehensive geographical clinical trial analysis of ongoing and planned studies related to medical devices. For the purpose of this analysis, we looked at the clinical studies that have been initiated since 2013 and analyzed them on the basis of various parameters, such as year of registration, regional distribution, current status of trials, therapeutic area(s) and disease indication(s), and number of patients enrolled across different geographies.
  • Chapter 9 features a detailed analysis of the mergers and acquisitions that have taken place in this space, highlighting the trend in the number of companies acquired from 2012-2018. The analysis also features an ownership change matrix, providing a summary of the involvement of private and public sector entities in this domain.
  • Chapter 10 presents insights from the survey conducted for this study. We invited over 200 stakeholders that provide CRO services to medical device developers. The participants, who were primarily Director / CXO level representatives of their respective companies, helped us develop a deeper understanding on the nature of their services and the associated commercial potential.
  • Chapter 11 presents a likely evolution of the market in the short to mid-term and long term, for the period 2018-2030. In addition, we have provided the likely distribution of the opportunity across different [A] type of therapeutic areas (bone disorders, cardiological disorders, dental disorders, metabolic disorders, neurological disorders, ophthalmic disorders, respiratory disorders, wound management and others), [B] geographical regions (covering North America, Europe, Asia-Pacific and rest of the world), [C] type of device class (class I, class II and class III), [D] phase of development (clinical and preclinical) and [E] type of services offered (clinical trial management, data management, regulatory affairs management, consulting and others).
  • Chapter 12 provides a discussion on affiliated trends, key drivers and challenges, under a comprehensive SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall medical devices CRO industry.
  • Chapter 13 presents a discussion on the upcoming opportunities / trends of medical device contract services market that are likely to impact the future evolution of this domain over the coming years. These include (but not limited to) increase in number of connected devices, advancement of data analytics and real-time monitoring solutions, growing need for cloud-based data storage solutions and introduction of real world evidence.
  • Chapter 14 is a collection of interview transcripts of the discussions held with key stakeholders in this market.
  • Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures included in the report.
  • Chapter 16 is an appendix, which contains a list of companies and organizations mentioned in this report.
Note: Product cover images may vary from those shown
5 of 5
  • 1Med
  • 3D Clinical Research
  • 4Clinics
  • A+ Science
  • Absorption Systems
  • ABX-CRO
  • Acceliant
  • AccelLAB
  • Accelovance
  • AccuLab Life Sciences
  • Accutest
  • acromion
  • ACROSS Medical
  • Activa Cro
  • ADAX International
  • Advance Research Associates
  • Advanced Medical Research
  • Affinity Bio Partners
  • Agility Clinical
  • AGINKO Research
  • AICROS
  • AKRN Scientific Consulting
  • Altair Clinical
  • AMANO Clinical Consulting
  • Amarex
  • American Preclinical Services
  • AmeRuss Clinical Trials
  • Amulet Capital Partners
  • analyze & realize
  • Andaman Medical
  • APICES
  • Appletree CI Group
  • Applied Clinical Services
  • Archemin
  • Asiatic Clinical Research
  • ASKLEP
  • ATLANSTAT
  • AtoZ-CRO
  • AVANTI
  • AVIAD Life Sciences
  • Axcent Advanced Analytics
  • Axonal-Biostatem
  • Azelix
  • Beaufort
  • BioAgile Therapeutics
  • Biomapas
  • Bioneeds
  • Biorasi
  • Bioscience
  • BiTrial Clinical Research
  • BLS laboratories
  • Boston Biomedical Associates
  • Boston MedTech Advisors
  • Bridge Pharm
  • Bridge PTS
  • Cardialysis
  • Cardinal Systems
  • CardioMed Device Consultants
  • Cardiovascular European Research Center (CERC)
  • CARE Research
  • Caritas Clinical
  • CarthagoPharma
  • Catawba Research
  • Cato Research
  • CBSET
  • CC Clinical research Consultants
  • CeeTox
  • C'en Al Research
  • Charles River Laboratories
  • Chemical Inspection and Regulation Service
  • Chiltern
  • China Med Device
  • CiToxLAB
  • Clinical Device Group
  • Clinical Research & Compliance Consulting
  • Clinipace
  • CliniQAl International
  • Clinlogix
  • Clinmark
  • ClinMed Pharma
  • Clinnex
  • ClinSync
  • Clintec
  • Cmed
  • CMIC Group
  • Cobridge
  • Cognitive Research
  • CONET
  • Convex
  • Courante Oncology
  • CPS Cortex
  • CRA Holdings
  • Cromos Pharma
  • CROMSOURCE
  • CROs NT
  • Crown CRO
  • CRS Clinical Research Services
  • CSSi LifeSciences
  • CTI
  • CTServ
  • CurAccel
  • Cvigilance
  • CW Research & Management
  • Cyprotex
  • Databean
  • Datapharm
  • Devicia
  • DFS Pharma
  • dMed
  • dn8 collaborate
  • Donawa Lifescience Consulting
  • Dor Pharmaceutical Services
  • Dove Quality Solutions
  • DP Clinical
  • DZS Clinical Services
  • EMEACR
  • Emergent Clinical Consulting
  • Emergo
  • En Pointe Clinical Research
  • EPIC Research CRO
  • ERA Clinical
  • ESTERN Medical
  • Ethicare Clinical Trial Services
  • Eurofins
  • Eurotrials Scientific
  • Factory CRO
  • FGK Clinical Research
  • Firma Clinical Research
  • Five Corners
  • FMD K&L
  • Fountain Medical Development
  • GCE Solutions
  • GCP-Service International
  • GDFI
  • Genae
  • Genco Medical
  • Genelife Clinical Research
  • George Clinical
  • GKM
  • Global Pharma Tek
  • Gsap
  • Hangzhou Tigermed Consulting
  • Harrison Clinical Research
  • Herac
  • Hilbert Paradox
  • HungaroTrial
  • ICBio
  • ICON
  • ICRC-Weyer
  • ikfe CRO
  • Illingworth Research Group
  • IMARC Research
  • Innovo Medical
  • InrexTest
  • Integrated Research
  • Integrated Resources
  • International Clinical Trials Association
  • International HealthCare
  • Ipsum
  • IQVIA
  • Iris Pharma
  • IRW
  • ITEC Services
  • ITOCHU
  • IVD Consultants
  • JSS Medical Research
  • Jyton
  • KCR
  • KCRI
  • KPS Clinical Services
  • Kun Tuo
  • LabCorp
  • Lambda Therapeutic Research
  • Larix
  • LatAm Clinical Trials
  • Leon Research
  • Linical Accelovance Group
  • LINK Medical
  • LNAge
  • Macnair Consultants
  • Made Consulting
  • MakroCare
  • MAXIS
  • MD-Clinicals
  • Medelis
  • Medfiles
  • Medicomp
  • MedicSense
  • Medidee
  • Medikapoli
  • MediTech Strategic Consultants
  • Meditrial
  • Meditrial Europe
  • Medpace
  • MedPass International
  • MedQ Consultants
  • MedVigil Clinical Research
  • Mene Research
  • Mericon
  • Metrics Research
  • MileStone Research
  • Mobius Medical
  • Morley Research Consortium
  • MPI Research
  • Musculoskeletal Clinical Regulatory Advisers
  • NAMSA
  • Navitas Life Science
  • NCGS
  • Neometrix Consulting
  • Neox Clinical Research
  • Neozene
  • New England Research Institutes (NERI)
  • Noble Life Sciences
  • Novella Clinical
  • NOVO Consulting Group
  • Novum
  • NoyMed
  • O4 Research
  • OCT
  • Odelle Technology
  • Onorach
  • OPIS
  • Optimal Pharm / Tox Consulting
  • Optimal Research
  • Ora
  • Osmunda
  • OThree Consulting
  • Pacific BioLabs
  • Pacific Bridge Medical
  • Pacific Clinical Research Group (PCRG)
  • Pamplona Capital Management
  • Paragon Biomedical
  • PAREXEL International
  • PDR Partners
  • Pearl Pathways
  • Pepgra
  • Pharma Consulting Group
  • Pharmaceutical Development Company
  • Pharmaceutical Product Development (PPD)
  • Pharmahungary Group
  • PharmaMed Research
  • Pharmaseed
  • Phidea Group
  • Pilgrim Quality Solutions
  • Pivotal
  • Pleiad
  • PMI Preclinical
  • PRADO
  • PRC Clinical
  • Preclinical Medevice Innovations
  • PreClinical Pathfinder
  • Premier Research
  • Promedica International
  • Prosoft Clinical
  • ProTrials Research
  • Proxima Research
  • Qmed Consulting
  • QServe
  • QST Consultations
  • Q-Trials
  • Quality and Compliance Consulting
  • Quanticate
  • Radiant Development
  • Radiant Research
  • Ratos
  • ReadyClinical
  • Regulatory & Clinical Research Institute
  • Remo CRO
  • Research & Development RA
  • Research Professionals
  • Rho
  • RJR Consulting
  • RMF Clinical
  • Rotrial
  • RQMIS
  • Scandinavian CRO
  • SCIderm
  • Scope International
  • Seoul CRO
  • Southern Star Research
  • SPRIM Advanced Life Sciences
  • Spring Valley Laboratories
  • STATKING Clinical Services
  • Stat-Tech Services
  • SterlingBio
  • Surpass-Silicon Valley
  • Symbion Research
  • Syneos Health
  • Syntax
  • Synteract
  • T3 Labs (Translational, Testing and Training Laboratories)
  • TAB Clinical
  • TCA Clinical Research
  • TechnoSTAT
  • TFS
  • The CLINICAL TRIAL Company Group
  • The CRO Group
  • The Medical Affairs Company
  • Theorem Clinical Research
  • TheraGenesis
  • ThreeWire
  • Toxikon
  • Vantage BioTrials
  • Venn Life Sciences
  • Veristat
  • Vimta Labs
  • Vivotecnia
  • WCCT Global
  • WDB Holdings
  • Winonco
  • WuXi AppTec
  • Xellent Health
  • Zeincro
  • Zetalix Solutions
  • Zymetrix
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll